Dhivy™(carbidopa/levodopa) – New drug approval
On November 12, 2021, the FDA approved Riverside Pharmaceutical’s Dhivy (carbidopa/levodopa) tablets, for the treatment of Parkinson’s disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
Top